Literature DB >> 4708713

Selective destruction of adrenergic nerve terminals by chemical analogues of 6-hydroxydopamine.

J P Tranzer, H Thoenen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4708713     DOI： 10.1007/BF01926498

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  7 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Improved technique for the fluorimetric estimation of catecholamines.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1961-04

3.  [Electron microscopy studies on the peripheral sympathetic nervous system of the cat; physiological and pharmacological aspects].

Authors:  J P Tranzer; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

4.  An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine.

Authors:  J P Tranzer; H Thoenen
Journal:  Experientia       Date:  1968-02-15

5.  Model experiments on the molecular mechanism of action of 6-hydroxydopamine.

Authors:  A Saner; H Thoenen
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

6.  Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.

Authors:  G R Breese; T D Traylor
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

7.  Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine.

Authors:  R Heikkila; G Cohen
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728
  7 in total
  7 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

3.  The effect of 5,7-dihydroxytryptamine on peripheral adrenergic nerves in the mouse.

Authors:  H G Baumgarten; H P Groth; M Göthert; A A Manian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 4.  A guide to neurotoxic animal models of Parkinson's disease.

Authors:  Kim Tieu
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 5.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

6.  Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Authors:  Valerie Joers; Kristine Dilley; Shahrose Rahman; Corinne Jones; Jeanette Shultz; Heather Simmons; Marina E Emborg
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 7.  Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care.

Authors:  Jun-Won Yun; Jae-Bum Ahn; Byeong-Cheol Kang
Journal:  Lab Anim Res       Date:  2015-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.